Why an Alliance for biomedical research is needed

Biomedical research in Europe is facing unprecedented challenges. Funding and support for research are far below that which has long been promised and is needed for sustained European competitiveness and innovations in biomedicine. New insights and therapeutic strategies are desperately needed to cope with the specific health-care problems of the ageing population. These challenges must be addressed at a European level but, unfortunately, European support currently falls short.

Download

European societies form biomedical alliance

A new European alliance of biomedical researchers has been launched to boost research funding and keep Europe competitive as China’s research investment soars. Tony Kirby reports.

Although the USA remains its main competitor, European biomedical research is facing a new threat from Asia, especially China, whose investment in research is increasing greatly. China’s thrivin economy means it can prioritise and substantially expand investment in biomedical research and development (R&D). But in Europe, austerity measures from the global financial crisis are forcing widespread cuts, leaving researchers there struggling simply to maintain the status quo.

Download

In a recent Brussels meeting, Dr Ruxandra Draghia-Akli, Director of the Health Directorate at Research Directorate-General of the European Commission, expressed deep concern about current EU funding earmarked for health projects. In response, major health-related societies across Europe have created an alliance to improve funding of biomedical research across the EU.

Download

Medical researchers from across Europe have come together in an effort to get their voices heard in debates on research funding and policy.

Download

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.